- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
Mochida Pharmaceutical
Market Cap: JP¥108.1b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥3,050.00
7D
-0.2%
1Y
-13.7%
KYORIN Pharmaceutical
Market Cap: JP¥82.2b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,430.00
7D
-1.0%
1Y
-5.7%
Hisamitsu Pharmaceutical
Market Cap: JP¥284.3b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,020.00
7D
-1.6%
1Y
-6.3%
Kaken Pharmaceutical
Market Cap: JP¥138.7b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,664.00
7D
-1.0%
1Y
-5.2%
Takara Bio
Market Cap: JP¥115.2b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥957.00
7D
-0.8%
1Y
-10.1%